Owners, management and financials
CVR: 33752245
Previous names: KR 554 A/S, AKTIESELSKABET AF 1. JUNI 2011 II, BN INFECTIOUS DISEASES A/S
Not available
Net result: DKK 45,369
BAVARIAN NORDIC A/S (100%)
CVR · view owners
Henrik Juuel
Board: Paul John Chaplin (chair) and 2 members
CVR · view management
Active
Founded 30 May 2011
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Aktieselskabet af 1. juni 2011 II
CVR · 10/12/2018
View the full event history
Aktieselskabet af 1. juni 2011 II is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named BN Washington D.C. Holding A/S and BN INFECTIOUS DISEASES A/S. The management consists of Henrik Juuel. The board consists of Paul John Chaplin (chair), Christian Boje Vilstrup and Henrik Juuel. The company is owned by BAVARIAN NORDIC A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 45,369 compared with DKK 105,289 the year before. Equity in the 2025 report amounted to DKK 4,054,297.
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for medicinal-branchen.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 45 t. | 4.1 mio. | 4.1 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | 105 t. | 4 mio. | 4 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | 78 t. | 3.9 mio. | 3.9 mio. | - | |
| 202201/01/2022 – 31/12/2022 | - | -13 t. | 3.8 mio. | 3.8 mio. | - | |
| 202101/01/2021 – 31/12/2021 | 0 | -34 t. | 3.9 mio. | 3.8 mio. | - | |
| 202001/01/2020 – 31/12/2020 | 0 | -36 t. | 3.9 mio. | 3.9 mio. | - | |
| 201901/01/2019 – 31/12/2019 | - | 33 t. | 3.9 mio. | 3.9 mio. | 0 | |
| 201801/01/2018 – 31/12/2018 | - | 1.7 mio. | 4 mio. | 3.9 mio. | 0 | |
| 201701/01/2017 – 31/12/2017 | - | -22 t. | 2.2 mio. | 2.2 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | -13 t. | 2.3 mio. | 2.2 mio. | - | |
| 201501/01/2015 – 31/12/2015 | - | -12 t. | 2.3 mio. | 2.3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | -10 t. | 2.3 mio. | 2.3 mio. | - | |
| 201301/01/2013 – 31/12/2013 | - | -10 t. | 2.3 mio. | 2.3 mio. | - | |
| 201201/01/2012 – 31/12/2012 | - | -8 t. | 2.3 mio. | 2.3 mio. | - |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Aktieselskabet af 1. juni 2011 II is 33752245.
Aktieselskabet af 1. juni 2011 II is owned by BAVARIAN NORDIC A/S.
The management of Aktieselskabet af 1. juni 2011 II consists of Henrik Juuel.
The board of Aktieselskabet af 1. juni 2011 II consists of Paul John Chaplin, Christian Boje Vilstrup and Henrik Juuel, with Paul John Chaplin as chair.
Aktieselskabet af 1. juni 2011 II had an average of 0 employees in the 2025 financial year according to the annual report.
Aktieselskabet af 1. juni 2011 II was founded on 30 May 2011.
Claim this page to add your logo and social links. Free to get started.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2025. The net result was DKK 45,369.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2024. The net result was DKK 105,289.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2023. The net result was DKK 77,791.
As of April 16, 2024, KPMG P/S has been appointed auditor of Aktieselskabet af 1. juni 2011 II.
As of April 16, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Aktieselskabet af 1. juni 2011 II.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2022. The net result was DKK -12,621.
As of March 30, 2023, Christian Boje Vilstrup has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of March 30, 2023, Morten Max Rasmussen has left the board of directors of Aktieselskabet af 1. juni 2011 II.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK -33,896.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK -35,587.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2019. The net result was DKK 33,275.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2018. The net result was DKK 1,656,428.
As of December 10, 2018, Henrik Juuel has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of December 10, 2018, Ole Larsen has left the board of directors of Aktieselskabet af 1. juni 2011 II.
As of December 10, 2018, Henrik Juuel is registered as director of Aktieselskabet af 1. juni 2011 II.
As of December 10, 2018, Ole Larsen has stepped down as director of Aktieselskabet af 1. juni 2011 II.
On December 10, 2018, the company changed its name from BN Washington D.C. Holding A/S to Aktieselskabet af 1. juni 2011 II.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2017. The net result was DKK -22,492.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2016. The net result was DKK -12,959.
As of July 15, 2016, Paul John Chaplin has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2015. The net result was DKK -11,855.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2014. The net result was DKK -10,244.
On April 23, 2015, the company changed its name from BN INFECTIOUS DISEASES A/S to BN Washington D.C. Holding A/S.
As of May 28, 2014, Anders Hedegaard has left the board of directors of Aktieselskabet af 1. juni 2011 II.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2013. The net result was DKK -9,937.
Aktieselskabet af 1. juni 2011 II has published its annual report for 2012. The net result was DKK -7,681.
On November 23, 2012, the company changed its name from AKTIESELSKABET AF 1. JUNI 2011 II to BN INFECTIOUS DISEASES A/S.
As of October 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Aktieselskabet af 1. juni 2011 II.
As of October 13, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has stepped down as auditor of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, REVISIONS- OG FORVALTNINGS- INSTITUTET, AKTIESELSKAB has been appointed auditor of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Anders Hedegaard has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Morten Max Rasmussen has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Ole Larsen has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Michael Egede Budtz has left the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Henrik Møgelmose has left the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Caroline Sundorph Pontoppidan has left the board of directors of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Ole Larsen is registered as director of Aktieselskabet af 1. juni 2011 II.
As of June 1, 2011, Caroline Sundorph Pontoppidan has stepped down as director of Aktieselskabet af 1. juni 2011 II.
On June 1, 2011, the company changed its name from KR 554 A/S to AKTIESELSKABET AF 1. JUNI 2011 II.
As of May 30, 2011, Michael Egede Budtz has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of May 30, 2011, Henrik Møgelmose has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of May 30, 2011, Caroline Sundorph Pontoppidan has joined the board of directors of Aktieselskabet af 1. juni 2011 II.
As of May 30, 2011, Caroline Sundorph Pontoppidan is registered as director of Aktieselskabet af 1. juni 2011 II.
As of May 30, 2011, BAVARIAN NORDIC A/S is registered as an owner of Aktieselskabet af 1. juni 2011 II with an ownership share of 100%.
Aktieselskabet af 1. juni 2011 II was founded on May 30, 2011.
Companies in the same industry and area
CVR 41366044
CVR 32971024
CVR 27701396
CVR 43932489
CVR 33687311
